37 participants
Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-11-27
- Start Date:
- 2022-11-06
- Completion:
- 2024-05-31
Conditions
- Ovarian Cancer
Interventions
- DRUG
No Results Yet